Immediate Impact
7 from Science/Nature 53 standout
Citing Papers
Tumor metabolic regulators: key drivers of metabolic reprogramming and the promising targets in cancer therapy
2025 Standout
Advances in cancer immunotherapy: historical perspectives, current developments, and future directions
2025 Standout
Works of Y. Li being referenced
Clinicopathological and genomic correlates of programmed cell death ligand 1 (PD-L1) expression in nonsquamous non-small-cell lung cancer
2020
Phase I dose-finding study of paclitaxel with panitumumab, carboplatin and intensity-modulated radiotherapy in patients with locally advanced squamous cell cancer of the head and neck
2009
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Y. Li | 267 | 32 | 114 | 215 | 17 | 500 | |
| Stef van Lieshout | 237 | 23 | 90 | 201 | 11 | 505 | |
| Zhongzong Pan | 300 | 19 | 78 | 80 | 13 | 457 | |
| Nisha Durand | 202 | 53 | 97 | 77 | 23 | 461 | |
| Min Li | 187 | 96 | 69 | 69 | 19 | 523 | |
| S Povey | 279 | 34 | 66 | 98 | 16 | 534 | |
| Jennifer Wright | 326 | 32 | 76 | 81 | 19 | 517 | |
| Silvana Caristi | 215 | 28 | 134 | 115 | 21 | 542 | |
| Louise H. Williams | 324 | 22 | 89 | 66 | 15 | 493 | |
| Ilaria Gori | 284 | 14 | 74 | 80 | 17 | 574 | |
| Zhen Geng | 260 | 52 | 103 | 46 | 13 | 555 |
All Works
Login with ORCID to disown or claim papers
Loading papers...